Francis R. Amato
Prior to joining electroCore, Frank spent 22 years within the pharmaceutical industry, most recently as Vice President of the Specialty Commercial Operations Group, Global Human Health at Merck. Frank has extensive commercial experience through such previous roles as Executive Director, Global Business Operations, Schering-Plough; Business Unit Lead, Oncology, Ligand Pharmaceuticals; National Sales Director, Specialty Managed Markets, Pfizer Inc.; and National Sales Director Hospitals, Pharmacia Corporation. Frank joined The Upjohn Company in 1990 as a sales representative in NYC. Prior to joining the pharmaceutical industry, he was an Infantry Medic in the 82nd Airborne Division of the United States Army.
Chief Executive Officer
Frank received his Executive MBA from Pepperdine University’s Graziadio School of Management in 2005 and an undergraduate degree in Political Science from St. John’s University in 1990.
JP received his undergraduate degree in aeronautical engineering from the Massachusetts Institute of Technology and worked at the Air Force National Laboratory, Lincoln Laboratories. He holds both law and mechanical/materials engineering graduate degrees from Duke University. JP trained as a patent attorney in New York and is the author of a treatise on international intellectual property law. Along with fellow investor and board member Dr. Thomas Errico, JP has founded a number of medical device companies, including Fastenetix, K2 Medical, AD-4 Pharma, E2, and SpineCore. Products conceived by these companies have generated more than $12 billion in sales to date. He served as the CEO of SpineCore from the inception of the company through its sale to Stryker in July 2004.
Founder, Chief Science & Strategy Officer
JP is a named inventor on more than 125 issued US patents and is a named inventor on more than 100 pending US applications. Additional patents and patent applications outside the US on which he is a named inventor number greater than 200. In addition to his current role as CSSO, he continues also to make significant inventive contributions in all aspects of the company’s key patent portfolios, along with the clinical and market validations of the company’s products and their indications.
Steve is a Research and Development executive with 28 years of experience driving all phases of product life cycle, from concept/patents and design to manufacturing and sales/field support. Previously Vice President of Development with the EBI division of Biomet, Steve was responsible for electronic, bracing, and softgood products in addition to overseeing the development of external and implantable electrical/thermal therapy medical devices. He also established and managed electronic production/test/repair departments at EBI and previous employers.
Founder, Chief Technical Officer
Steve obtained an MSEE from Rensselaer Polytechnic Institute, and a BSEE and BA Biology from Lehigh University.
Glenn S. Vraniak
Glenn has been an executive officer in the healthcare sector for over 13 years. Most recently he was the CFO of G&W Laboratories, a mid-cap specialty pharmaceutical company, where he executed the company’s growth strategy by acquiring 2 companies and over 35 products. Prior to that, he was the President of Aprecia Pharmaceuticals, a 3DP technology enabled pharmaceutical company, where he succeeded in developing the company’s commercial strategy in neurology and raising significant capital. From 2003 through 2011, Glenn was the CFO and Head of Strategic Planning for Prasco Laboratories, the fastest growing generic pharmaceutical company in the U.S. for three consecutive years. He also spent time as an Executive VP for GE Capital and subsequently founded Preceptus, his own boutique consulting firm focused on helping small and mid-market companies achieve efficient and scalable growth in the healthcare and technology sectors.
Chief Financial Officer
Glenn holds an Electronic Engineering Technology degree and a Managerial MBA in Finance from the Rutgers University Center for Management Development.
Bruce J. Simon, PhD
Prior to joining electroCore, Bruce spent 16 years as Senior Director of Research at EBI (a division of Biomet, Inc.) where he directed research on the effects of electric and electromagnetic fields on bone, cartilage and soft tissue repair. He has more than 60 peer-reviewed publications and 40 issued or pending patents.
Vice President, Research
Bruce obtained a B.S. in Physics from the Massachusetts Institute of Technology and a Ph.D. in Physiology and Biophysics from the University of Iowa. After completing his Ph.D., he spent several years as a Research Assistant Professor at the University of Maryland and then as an Assistant Professor at the University of Texas. His research focused on various aspects of electrophysiology, including excitation-contraction coupling in muscle and biophysical modeling.
Eric brings more than 20 years of neurological industry and association experience to electroCore. In 2009, he co-founded Nautilus Neurosciences, a neurology-focused specialty pharmaceutical company focused on identifying and developing drugs benefiting those affected by neurological disorders, to market Cambia® for the treatment of acute migraine. At Nautilus, Eric was involved in all facets of the company’s organization and early success, including initial funding, product commercialization, and sales and marketing.
Vice President, Scientific, Medical and Governmental Affairs
Eric has held leadership positions at Elan, Amarin, Enzon Pharmaceuticals, Questcor Pharmaceuticals, and Pharmacopeia. He founded Nisola LLC, an advocacy and business strategy-consulting firm focused on serving clients in the field of neurology, and sat on the Board of Trustees of the American Academy of Neurology Foundation (now the American Brain Foundation) for more than a decade. Eric began his career at Athena Neurosciences, a pioneer in the development of neurology drugs, after graduating with Honors from Tufts University.
Mike is a Quality Assurance and Regulatory Compliance executive with 35 years of experience in the medical device industry, including manufacturing, design and development, and quality management. Mike has led the successful development and deployment of quality management systems established to meet US FDA as well as international regulatory requirements for several organizations. Prior to joining electroCore, Mike served as the Director of Quality Assurance and Regulatory Compliance at Blackstone Medical, Inc., where he was responsible for product quality control, quality engineering, supplier management, and product complaint handling, as well as the management of field actions and recalls.
Vice President, Quality Assurance
Prior to joining electroCore, Dan was Global Vice President for Business Development with Touchpoint Solutions. In addition, Dan has served in senior sales and marketing roles, most recently at Amylin Pharmaceuticals, where he developed, recruited and led diabetes-specialty sales teams accountable for the successful commercial launch of Byetta and Symlin. Dan has developed his knowledge of sales and marketing alignment through experience in commercial roles with Novartis, Pharmacia Corporation and Schering Plough. Dan believes customer value creation comes from identifying novel solutions for clients’ most complex initiatives, which is the key to long-term client partnership.
Global Vice President, Sales and Marketing
Dan received his BS in Business Administration, Finance from University California, Northridge.
Peter S. Staats
Peter is an Adjunct Associate Professor in the Department of Anesthesiology and Critical Care Medicine and the Department of Oncology at Johns Hopkins University School of Medicine in Baltimore, Maryland. He was the founder of the Division of Pain Medicine at Johns Hopkins University, where he was the director for ten years. Peter is internationally known for developing and implementing minimally invasive procedures for chronic pain. Peter received his medical degree from the University of Michigan Medical School in Ann Arbor and completed his residency and fellowship training at the Johns Hopkins University School of Medicine. He is certified by the National Board of Medical Examiners, the American Board of Pain Medicine, and the American Board of Anesthesiology, and is a fellow of the World Institute of Pain and the North American Neuromodulation Society.
Chief Medical Officer
Peter has written or co-edited five books and close to two hundred articles, abstracts, monographs and book chapters on pain medicine in publications that include the Journal of the American Medicine Association, Pain, Anesthesiology, and the Journal of Clinical Oncology. His work has been highlighted on Good Morning America, CBS Evening News and CNN. He has lectured extensively nationally and internationally for over 10 years. In addition to his numerous editorial board appointments, including the Clinical Journal of Pain and Pain Medicine, Peter is an active member in many professional societies and is past president of the North American Neuromodulation Society and the Southern Pain Society.